The Federal Trade Commission said Tuesday it has launched a probe into the business practices of vertically integrated pharmacy benefit managers, requiring the six largest companies in the industry to hand over business records to help the agency determine whether they are negatively impacting affordability and access to prescription drugs.
The Federal Trade Commission is requiring the six largest pharmacy benefit managers to provide information and records regarding their business practices. The agency is launching an inquiry into what it called the prescription drug middleman industry to scrutinize the impact of vertically integrated pharmacy benefit managers on the access and affordability of prescription